Diabetes Education

Top Story

Glycemic control, drug regimen interaction influence mortality risk in type 2 diabetes

November 17, 2017

Adults with type 2 diabetes who achieve low HbA1c targets may have an increased risk for death, particularly when treated with regimens associated with hypoglycemia, compared with adults with moderate HbA1c levels, epidemiologic data show.

“Contrary to commonly held beliefs, we don’t yet fully understand the association between glucose control and some serious outcomes, including mortality,” Craig J. Currie, PhD, professor of applied pharmacoepidemiology at the Cochrane Institute of Primary Care and Public Health, Cardiff University, U.K., told Endocrine Today. “We need to investigate thoroughly the epidemiology of outcome in relation to glucose control, and we need to use insulin cautiously in people with type 2 diabetes.”

In the Journals Plus

Childhood abuse, parental mental illness raise risk for type 2 diabetes in adulthood

November 17, 2017
Childhood trauma, including sexual, physical and verbal abuse, raises the risk for developing type 2 diabetes in adulthood by as much as 57%, according to an analysis…
Meeting NewsPerspective

Telepharmacy intervention yields modest effect on medication adherence among patients with cardiometabolic diseases

November 15, 2017
ANAHEIM, Calif. — Implementation of a personalized telepharmacy intervention improved medication adherence but did not affect measures of disease control including…
In the Journals Plus

Peer, parental relationships influence outcomes for teens, young adults with type 1 diabetes

November 15, 2017
Adolescents and emerging adults with type 1 diabetes who report supportive peer and parental relationships are more likely to report less emotional and food- and…
More Headlines »
CME

Practical Lipidology® Volume 4, Number 1: Focus on LDL Reduction and PCSK9 Inhibition

This activity is supported by an educational grant from Amgen

A preponderance of data shows that low-density lipoprotein cholesterol (LDL-C) plays a causal role in atherosclerotic…
More »
Video
Meeting News

VIDEO: Diabetes language matters

August 5, 2017
More »
Resource Centers
ObesityWeek

ObesityWeek

CME CE

Innovations in Insulin: New Opportunities to Individualize Therapy

Presented by the Annenberg Center for Health Sciences.
This activity is supported by an independent educational grant from Novo Nordisk Inc.
This activity is supported by an educational grant from Lilly.

Vivian A. Fonseca, MD, and Jonathan D. Leffert, MD, combine their expertise and discuss emerging concepts, treatment…
More »
Advertisement
Advertisement